Reasons Viking Therapeutics Stock Could 10X If Obesity
Investors are watching Viking Therapeutics as its obesity drug candidate approaches key milestones. This article brea...
Overview of beginner-friendly HYSA options, focusing on accessibility, straightforward terms, and competitive rates.
24,631 articlesInvestors are watching Viking Therapeutics as its obesity drug candidate approaches key milestones. This article brea...
Take-Two Interactive faces a mix of franchise strength and execution risks. This article breaks down whether the stoc...
A major fund exits a Buckle stake, triggering questions about strategy and market signals. This article breaks down w...
Eli Lilly has faced a pullback that can create long-term buying opportunities. This guide explores using a budget-fri...
Peloton posted a GAAP profit in its latest quarter and raised full-year guidance, sparking an 11% premarket jump as i...
Flyhomes has weathered a boom-bust housing cycle by recalibrating its business and embracing profitability over rapid...
Ready to put $3,000 to work? This practical guide shows a straightforward, diversified approach to investing in the b...
ServiceNow climbs as investors chase AI-driven growth in enterprise software, with Dell's recent results helping lift...
A new program from Morgan Stanley allows eligible wealth clients to lend crypto to Galaxy Digital in exchange for spo...
At the SuperAI Summit in Singapore, Yat Siu laid out a firms-wide thesis that Asia will merge AI and blockchain faste...
A stock that utterly failed decade may finally turn the corner. This guide breaks down three tangible reasons for a p...
A practical look at a top energy stock evolving at the crossroads of renewables and AI. Learn how to assess the setup...